OG_ID,Component_16,group_id,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_09295,2.7218615146397553,OG_09295,FUN_040146-T1,Peve_00038108,Pocillopora_meandrina_HIv1___RNAseq.g8511.t1,three_way,40.80866666666667,,,,,,,,,,,,,,,,,
OG_03671,2.145100056077,OG_03671,FUN_014916-T1,Peve_00003523,Pocillopora_meandrina_HIv1___RNAseq.g21079.t1,three_way,45.37166666666666,FUN_014916-T1,P00919,,,,,41.5,253.0,1.2e-44,183.0,sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3,,,,,,
OG_09806,2.0487523657387308,OG_09806,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_08222,1.955211693642799,OG_08222,FUN_036093-T1,Peve_00032189,Pocillopora_meandrina_HIv1___RNAseq.g27441.t1,three_way,76.63133333333333,FUN_036093-T1,Q68DA7,FMN1_HUMAN,,Formin-1 (Limb deformity protein homolog),Homo sapiens (Human),33.3,471.0,1.5e-63,246.1,sp|Q68DA7|FMN1_HUMAN Formin-1 OS=Homo sapiens OX=9606 GN=FMN1 PE=1 SV=3,GO:0003779; GO:0005634; GO:0005789; GO:0005884; GO:0005886; GO:0005912; GO:0008017; GO:0030036; GO:0045010,actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010],actin filament [GO:0005884]; adherens junction [GO:0005912]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886],actin binding [GO:0003779]; microtubule binding [GO:0008017],GO:0005634; GO:0005886; GO:0007010; GO:0008092; GO:0043226,nucleus; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_02090,1.9094502486505829,OG_02090,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_08842,1.908839774732655,OG_08842,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_03779,1.908077436577388,OG_03779,FUN_015109-T1,Peve_00024001,Pocillopora_meandrina_HIv1___RNAseq.g21738.t1,three_way,67.93483333333333,FUN_015109-T1,Q9QXZ0,MACF1_MOUSE,,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 (Actin cross-linking family 7)",Mus musculus (Mouse),25.3,2944.0,1.6e-256,890.6,"sp|Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 OS=Mus musculus OX=10090 GN=Macf1 PE=1 SV=2",GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005938; GO:0006620; GO:0007163; GO:0008017; GO:0008104; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893; GO:0150011,cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011],GO:0003824; GO:0005794; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0042060; GO:0043226; GO:0048870; GO:0072659,catalytic activity; Golgi apparatus; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; wound healing; organelle; cell motility; protein localization to plasma membrane
OG_04560,1.898195738912168,OG_04560,FUN_022199-T1,Peve_00041449,Pocillopora_meandrina_HIv1___RNAseq.g4798.t1,three_way,67.538,,,,,,,,,,,,,,,,,
OG_06109,1.89488201832635,OG_06109,FUN_027814-T1,Peve_00036499,Pocillopora_meandrina_HIv1___RNAseq.g13890.t1,three_way,84.264,FUN_027814-T1,O00571,DDX3X_HUMAN,,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)",Homo sapiens (Human),71.5,425.0,1.6999999999999996e-177,623.6,sp|O00571|DDX3X_HUMAN ATP-dependent RNA helicase DDX3X OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=3,GO:0002753; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010628; GO:0010629; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031252; GO:0031333; GO:0031369; GO:0032481; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035591; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043186; GO:0043273; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0070131; GO:0071243; GO:0071470; GO:0071651; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243,cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytosolic ribosome assembly [GO:0042256]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055],cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; signaling adaptor activity [GO:0035591]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0060090; GO:0098542; GO:0098772; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; GTPase activity; extracellular region; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; molecular adaptor activity; defense response to other organism; molecular function regulator activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05875,1.870436113876329,OG_05875,FUN_026024-T1,Peve_00026729,Pocillopora_meandrina_HIv1___RNAseq.g10496.t1,three_way,59.858,FUN_026024-T1,O46392,,,,,37.0,216.0,5.4e-35,152.1,sp|O46392|CO1A2_CANLF Collagen alpha-2(I) chain OS=Canis lupus familiaris OX=9615 GN=COL1A2 PE=2 SV=2,,,,,,
OG_05874,1.862096481390253,OG_05874,FUN_026023-T1,Peve_00026728,Pocillopora_meandrina_HIv1___RNAseq.g10495.t1,three_way,61.43916666666667,FUN_026023-T1,Q91717,,,,,31.0,277.0,2.3e-26,123.6,sp|Q91717|CO2A1_XENLA Collagen alpha-1(II) chain OS=Xenopus laevis OX=8355 GN=col2a1 PE=2 SV=2,,,,,,
OG_09120,1.8392706606720264,OG_09120,FUN_039266-T1,Peve_00002772,Pocillopora_meandrina_HIv1___RNAseq.g13577.t1,three_way,76.14266666666667,FUN_039266-T1,P12394,,,,,43.7,462.0,3.8999999999999998e-109,396.7,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_03845,1.8212571679774223,OG_03845,FUN_015318-T1,Peve_00023982,Pocillopora_meandrina_HIv1___RNAseq.g21728.t1,three_way,82.93366666666667,FUN_015318-T1,Q5QNI2,,,,,31.0,532.0,4.7999999999999997e-54,213.8,sp|Q5QNI2|NCL1_ORYSJ Sodium/calcium exchanger NCL1 OS=Oryza sativa subsp. japonica OX=39947 GN=NCL1 PE=2 SV=1,,,,,,
OG_08540,1.8144075920653353,OG_08540,FUN_037491-T1,Peve_00028570,Pocillopora_meandrina_HIv1___RNAseq.g1307.t1,three_way,88.51766666666667,FUN_037491-T1,P31153,METK2_HUMAN,,S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II),Homo sapiens (Human),79.0,381.0,3.6e-177,622.5,sp|P31153|METK2_HUMAN S-adenosylmethionine synthase isoform type-2 OS=Homo sapiens OX=9606 GN=MAT2A PE=1 SV=1,GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0034214; GO:0036094; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:0061431; GO:1904263; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to methionine [GO:0061431]; one-carbon metabolic process [GO:0006730]; positive regulation of TORC1 signaling [GO:1904263]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556],cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; small molecule binding [GO:0036094],GO:0003824; GO:0005829; GO:0006790; GO:0016740; GO:0065003,catalytic activity; cytosol; sulfur compound metabolic process; transferase activity; protein-containing complex assembly
OG_09597,1.807762499751274,OG_09597,FUN_041744-T1,Peve_00000340,Pocillopora_meandrina_HIv1___RNAseq.g15789.t1,three_way,72.12516666666667,,,,,,,,,,,,,,,,,
OG_02540,1.8066061650267409,OG_02540,FUN_010623-T1,Peve_00004505,Pocillopora_meandrina_HIv1___RNAseq.g21294.t1,three_way,68.17916666666667,FUN_010623-T1,Q91VZ6,SMAP1_MOUSE,,Stromal membrane-associated protein 1,Mus musculus (Mouse),63.0,138.0,4.2999999999999996e-46,187.2,sp|Q91VZ6|SMAP1_MOUSE Stromal membrane-associated protein 1 OS=Mus musculus OX=10090 GN=Smap1 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005886; GO:0008270; GO:0030276; GO:0045648; GO:2000369,positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005886; GO:0098772,plasma membrane; molecular function regulator activity
OG_00402,1.804291621605764,OG_00402,FUN_001289-T1,Peve_00037015,Pocillopora_meandrina_HIv1___TS.g4708.t1a,three_way,81.49916666666667,FUN_001289-T1,Q9ULJ6,,,,,45.5,1166.0,3.5e-155,550.8,sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3,,,,,,
OG_06181,1.7997699589596432,OG_06181,FUN_028088-T1,Peve_00031660,Pocillopora_meandrina_HIv1___TS.g11574.t1,three_way,88.21483333333333,FUN_028088-T1,P18907,,,,,76.6,988.0,0.0,1502.3,sp|P18907|AT1A1_HORSE Sodium/potassium-transporting ATPase subunit alpha-1 OS=Equus caballus OX=9796 GN=ATP1A1 PE=3 SV=1,,,,,,
OG_07641,1.7972713713717343,OG_07641,FUN_034420-T1,Peve_00021291,Pocillopora_meandrina_HIv1___RNAseq.g28575.t1,three_way,76.00066666666666,FUN_034420-T1,Q32LP4,S4A10_BOVIN,,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),Bos taurus (Bovine),48.4,1093.0,1.6000000000000002e-273,944.1,sp|Q32LP4|S4A10_BOVIN Sodium-driven chloride bicarbonate exchanger OS=Bos taurus OX=9913 GN=SLC4A10 PE=2 SV=1,GO:0005452; GO:0005886; GO:0007601; GO:0008509; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0030425; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0051453; GO:0055085; GO:0098794; GO:0098982,bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; transmembrane transport [GO:0055085]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202],monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_00661,1.7950613260796071,OG_00661,FUN_001954-T1,Peve_00024484,Pocillopora_meandrina_HIv1___RNAseq.g29228.t1,three_way,86.64866666666667,FUN_001954-T1,Q6FIF0,ZFAN6_HUMAN,,AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3),Homo sapiens (Human),38.9,208.0,1.9e-29,130.6,sp|Q6FIF0|ZFAN6_HUMAN AN1-type zinc finger protein 6 OS=Homo sapiens OX=9606 GN=ZFAND6 PE=1 SV=2,GO:0003677; GO:0005829; GO:0006625; GO:0006915; GO:0008270; GO:0015031; GO:0031593; GO:0043066; GO:0043122; GO:0071356,apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; protein transport [GO:0015031]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cytosol [GO:0005829],DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270],GO:0003677; GO:0005829; GO:0012501,DNA binding; cytosol; programmed cell death
OG_09811,1.782105345668266,OG_09811,FUN_042633-T1,Peve_00030033,Pocillopora_meandrina_HIv1___RNAseq.19516_t,three_way,82.042,FUN_042633-T1,P08651,NFIC_HUMAN,,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),Homo sapiens (Human),48.2,390.0,3.2e-79,297.7,sp|P08651|NFIC_HUMAN Nuclear factor 1 C-type OS=Homo sapiens OX=9606 GN=NFIC PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006357; GO:0006366; GO:0042475; GO:0045944; GO:1990837,DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA replication; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04601,1.76932440071977,OG_04601,FUN_022288-T1,Peve_00003595,Pocillopora_meandrina_HIv1___RNAseq.g4695.t1,three_way,67.76066666666667,FUN_022288-T1,Q9Z340,PARD3_RAT,,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (Atypical PKC-specific-binding protein) (ASBP),Rattus norvegicus (Rat),32.5,805.0,1.7e-76,289.7,sp|Q9Z340|PARD3_RAT Partitioning defective 3 homolog OS=Rattus norvegicus OX=10116 GN=Pard3 PE=1 SV=1,GO:0000226; GO:0002092; GO:0003383; GO:0005546; GO:0005547; GO:0005737; GO:0005819; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007155; GO:0008104; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032970; GO:0032991; GO:0033269; GO:0035091; GO:0042802; GO:0043025; GO:0043219; GO:0043220; GO:0043296; GO:0044295; GO:0044319; GO:0045197; GO:0051301; GO:0051642; GO:0051660; GO:0060341; GO:0070830; GO:0090162; GO:0120157,"apical constriction [GO:0003383]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome localization [GO:0051642]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; positive regulation of receptor internalization [GO:0002092]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; regulation of actin filament-based process [GO:0032970]; regulation of cellular localization [GO:0060341]; wound healing, spreading of cells [GO:0044319]",adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; lateral loop [GO:0043219]; neuronal cell body [GO:0043025]; PAR polarity complex [GO:0120157]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]",GO:0007010; GO:0007155; GO:0007163; GO:0008289; GO:0034330; GO:0043226; GO:0048870,cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell junction organization; organelle; cell motility
OG_02929,1.7610981971626944,OG_02929,FUN_012028-T1,Peve_00030379,Pocillopora_meandrina_HIv1___RNAseq.g24047.t2,three_way,77.09433333333334,FUN_012028-T1,Q14192,FHL2_HUMAN,,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),Homo sapiens (Human),42.1,273.0,1.7000000000000002e-74,282.0,sp|Q14192|FHL2_HUMAN Four and a half LIM domains protein 2 OS=Homo sapiens OX=9606 GN=FHL2 PE=1 SV=3,GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885,atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018],bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_01177,1.760344101138854,OG_01177,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_09247,1.7545771187792054,OG_09247,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09472,1.7525025973141533,OG_09472,FUN_041498-T1,Peve_00007700,Pocillopora_meandrina_HIv1___TS.g10682.t1,three_way,80.48866666666666,FUN_041498-T1,Q6Q2B2,,,,,39.5,253.0,1.1e-33,145.6,sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1,,,,,,
OG_09808,1.7509450648522022,OG_09808,FUN_042630-T1,Peve_00033746,Pocillopora_meandrina_HIv1___RNAseq.g11507.t1,three_way,66.90383333333334,FUN_042630-T1,Q8TEK3,DOT1L_HUMAN,,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)",Homo sapiens (Human),42.8,636.0,2.0999999999999998e-129,465.7,"sp|Q8TEK3|DOT1L_HUMAN Histone-lysine N-methyltransferase, H3 lysine-79 specific OS=Homo sapiens OX=9606 GN=DOT1L PE=1 SV=3",GO:0000077; GO:0000781; GO:0003676; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0010467; GO:0031151; GO:0031509; GO:0032200; GO:0032259; GO:0032991; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:0140938; GO:0140956; GO:2000677,DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; subtelomeric heterochromatin formation [GO:0031509]; telomere organization [GO:0032200],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K79 methyltransferase activity [GO:0031151]; histone H3K79 trimethyltransferase activity [GO:0140956]; histone methyltransferase activity [GO:0042054]; nucleic acid binding [GO:0003676]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0032200; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; telomere organization; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_07730,1.7504328269174845,OG_07730,FUN_034891-T1,Peve_00037339,Pocillopora_meandrina_HIv1___TS.g15151.t2,three_way,94.67133333333334,FUN_034891-T1,Q13951,,,,,57.1,170.0,1.1e-48,194.5,sp|Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2,,,,,,
OG_09598,1.7473250326006775,OG_09598,FUN_041745-T1,Peve_00000338,Pocillopora_meandrina_HIv1___RNAseq.g15790.t1,three_way,56.4945,,,,,,,,,,,,,,,,,
OG_04968,1.746806986617906,OG_04968,FUN_023073-T1,Peve_00014063,Pocillopora_meandrina_HIv1___RNAseq.g1646.t2,three_way,77.28333333333333,FUN_023073-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),42.4,2171.0,0.0,1587.8,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_01728,1.7441576098358498,OG_01728,FUN_007020-T1,Peve_00037180,Pocillopora_meandrina_HIv1___RNAseq.g20542.t1,three_way,63.67233333333333,FUN_007020-T1,Q6ZZY0,,,,,46.9,497.0,1.3e-139,499.6,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_05645,1.744000218151465,OG_05645,FUN_025363-T1,Peve_00040516,Pocillopora_meandrina_HIv1___RNAseq.g13346.t1,three_way,65.52933333333334,FUN_025363-T1,Q9ER65,CSTN2_MOUSE,,Calsyntenin-2,Mus musculus (Mouse),27.8,856.0,4.6e-77,291.2,sp|Q9ER65|CSTN2_MOUSE Calsyntenin-2 OS=Mus musculus OX=10090 GN=Clstn2 PE=1 SV=2,GO:0000139; GO:0005509; GO:0005789; GO:0007156; GO:0008306; GO:0009986; GO:0014069; GO:0030425; GO:0045211; GO:0050806; GO:0051965; GO:0098839; GO:0098978; GO:1904862,associative learning [GO:0008306]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inhibitory synapse assembly [GO:1904862]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806],cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211],calcium ion binding [GO:0005509],GO:0007155; GO:0034330; GO:0043226; GO:0050877,cell adhesion; cell junction organization; organelle; nervous system process
OG_03193,1.7247253196658094,OG_03193,FUN_012670-T1,Peve_00008660,Pocillopora_meandrina_HIv1___RNAseq.g22885.t1,three_way,76.15866666666666,FUN_012670-T1,Q5F464,,,,,48.0,256.0,2.8e-72,273.5,sp|Q5F464|LPP_CHICK Lipoma-preferred partner homolog OS=Gallus gallus OX=9031 GN=LPP PE=2 SV=1,,,,,,
OG_04261,1.7221535128142516,OG_04261,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,54.0,767.0,3.7e-223,777.3,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_04261,1.7221535128142516,OG_04261,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,38.5,78.0,0.002,47.4,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_02930,1.7217757674198542,OG_02930,FUN_012029-T1,Peve_00044958,Pocillopora_meandrina_HIv1___RNAseq.g24045.t1,three_way,82.663,FUN_012029-T1,P11533,,,,,29.7,3968.0,0.0,1575.5,sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1,,,,,,
OG_04983,1.7199503257322188,OG_04983,FUN_023110-T1,Peve_00000494,Pocillopora_meandrina_HIv1___RNAseq.g1701.t2,three_way,63.913,FUN_023110-T1,Q8IUR6,,,,,61.0,59.0,2e-11,71.6,sp|Q8IUR6|CRERF_HUMAN CREB3 regulatory factor OS=Homo sapiens OX=9606 GN=CREBRF PE=1 SV=2,,,,,,
OG_09216,1.7074751495340592,OG_09216,FUN_039935-T1,Peve_00036234,Pocillopora_meandrina_HIv1___RNAseq.g7328.t1,three_way,60.9255,FUN_039935-T1,Q3TLH4,,,,,29.5,451.0,5.8e-24,116.3,sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3,,,,,,
OG_03971,1.706889642216756,OG_03971,FUN_016125-T1,Peve_00013452,Pocillopora_meandrina_HIv1___RNAseq.g21531.t1,three_way,80.723,FUN_016125-T1,Q8VI36,PAXI_MOUSE,,Paxillin,Mus musculus (Mouse),52.0,471.0,3.8e-133,476.5,sp|Q8VI36|PAXI_MOUSE Paxillin OS=Mus musculus OX=10090 GN=Pxn PE=1 SV=1,GO:0005078; GO:0005856; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008360; GO:0016477; GO:0030027; GO:0030032; GO:0030159; GO:0031252; GO:0031663; GO:0034446; GO:0038191; GO:0045766; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:1900026,branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of angiogenesis [GO:0045766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179],cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027],BH4 domain binding [GO:0051435]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; signaling receptor complex adaptor activity [GO:0030159],GO:0005856; GO:0007010; GO:0007155; GO:0034330; GO:0043226; GO:0048870; GO:0060090,cytoskeleton; cytoskeleton organization; cell adhesion; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_01942,1.703392592640281,OG_01942,FUN_007995-T1,Peve_00018055,Pocillopora_meandrina_HIv1___RNAseq.g18162.t1,three_way,60.7,FUN_007995-T1,Q13308,,,,,32.5,1058.0,5.8e-147,523.5,sp|Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens OX=9606 GN=PTK7 PE=1 SV=2,,,,,,
OG_03674,1.701436002755845,OG_03674,FUN_014925-T1,Peve_00006270,Pocillopora_meandrina_HIv1___RNAseq.g21082.t1,three_way,77.86116666666666,FUN_014925-T1,Q9I9E0,,,,,43.7,581.0,9.9e-52,206.5,sp|Q9I9E0|TAOK3_CHICK Serine/threonine-protein kinase TAO3 OS=Gallus gallus OX=9031 GN=TAOK3 PE=2 SV=2,,,,,,
OG_01630,1.6996126742648436,OG_01630,FUN_006744-T1,Peve_00039581,Pocillopora_meandrina_HIv1___RNAseq.g20530.t1,three_way,63.90916666666666,FUN_006744-T1,Q8BNA6,FAT3_MOUSE,,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Mus musculus (Mouse),33.8,4122.0,0.0,2094.3,sp|Q8BNA6|FAT3_MOUSE Protocadherin Fat 3 OS=Mus musculus OX=10090 GN=Fat3 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:1904936; GO:2000171,cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842],dendrite [GO:0030425]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0048856; GO:0048870,plasma membrane; cell adhesion; anatomical structure development; cell motility
OG_07714,1.6953219319862685,OG_07714,FUN_034867-T1,Peve_00005778,Pocillopora_meandrina_HIv1___RNAseq.g27146.t1,three_way,75.34383333333334,FUN_034867-T1,Q28193,FURIN_BOVIN,,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Trans Golgi network protease furin),Bos taurus (Bovine),49.8,616.0,5.7e-165,582.8,sp|Q28193|FURIN_BOVIN Furin OS=Bos taurus OX=9913 GN=FURIN PE=1 SV=1,GO:0000139; GO:0004252; GO:0005576; GO:0005802; GO:0005886; GO:0008201; GO:0010008; GO:0016486; GO:0046872; GO:0140447; GO:1904399,cytokine precursor processing [GO:0140447]; peptide hormone processing [GO:0016486],endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_02112,1.6931296188521816,OG_02112,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_00213,1.6927754351604898,OG_00213,FUN_000932-T1,Peve_00009724,Pocillopora_meandrina_HIv1___RNAseq.g29460.t1,three_way,85.761,FUN_000932-T1,P00516,,,,,65.8,619.0,1.3e-240,833.9,sp|P00516|KGP1_BOVIN cGMP-dependent protein kinase 1 OS=Bos taurus OX=9913 GN=PRKG1 PE=1 SV=2,,,,,,
OG_09596,1.6901725357174424,OG_09596,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_03736,1.684092641007074,OG_03736,FUN_015036-T1,Peve_00024712,Pocillopora_meandrina_HIv1___RNAseq.g21165.t1,three_way,78.18966666666667,FUN_015036-T1,Q9BZ72,PITM2_HUMAN,,"Membrane-associated phosphatidylinositol transfer protein 2 (Phosphatidylinositol transfer protein, membrane-associated 2) (PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3) (NIR-3)",Homo sapiens (Human),42.6,1386.0,1.2e-287,991.1,sp|Q9BZ72|PITM2_HUMAN Membrane-associated phosphatidylinositol transfer protein 2 OS=Homo sapiens OX=9606 GN=PITPNM2 PE=1 SV=1,GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008525; GO:0008526; GO:0012505; GO:0016020; GO:0030971; GO:0031210; GO:0035091,phosphatidylinositol biosynthetic process [GO:0006661],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020],calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971],GO:0005215; GO:0005829; GO:0006629; GO:0008289,transporter activity; cytosol; lipid metabolic process; lipid binding
OG_07594,1.6831262436099217,OG_07594,FUN_034300-T1,Peve_00013958,Pocillopora_meandrina_HIv1___RNAseq.g28501.t1,three_way,80.99333333333334,FUN_034300-T1,Q86WG5,MTMRD_HUMAN,,Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2),Homo sapiens (Human),39.3,2002.0,0.0,1303.1,sp|Q86WG5|MTMRD_HUMAN Myotubularin-related protein 13 OS=Homo sapiens OX=9606 GN=SBF2 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005774; GO:0005829; GO:0006914; GO:0010008; GO:0016020; GO:0019208; GO:0019902; GO:0030424; GO:0035091; GO:0042552; GO:0042802; GO:0048471,autophagy [GO:0006914]; myelination [GO:0042552],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774],guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0006914; GO:0008289; GO:0098772,cytosol; autophagy; lipid binding; molecular function regulator activity
OG_05471,1.683092099386515,OG_05471,FUN_024454-T1,Peve_00010316,Pocillopora_meandrina_HIv1___RNAseq.g18577.t1,three_way,67.4025,FUN_024454-T1,Q5DTZ6,,,,,45.4,273.0,1.5e-58,228.4,sp|Q5DTZ6|RN150_MOUSE RING finger protein 150 OS=Mus musculus OX=10090 GN=Rnf150 PE=2 SV=2,,,,,,
OG_08928,1.6770296182850168,OG_08928,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_02338,1.676547084018881,OG_02338,FUN_008934-T1,Peve_00036402,Pocillopora_meandrina_HIv1___RNAseq.g14257.t1,three_way,76.08966666666667,FUN_008934-T1,A5D7I4,EXT1_BOVIN,,Exostosin-1 (EC 2.4.1.225) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase),Bos taurus (Bovine),50.3,749.0,7.999999999999999e-217,755.0,sp|A5D7I4|EXT1_BOVIN Exostosin-1 OS=Bos taurus OX=9913 GN=EXT1 PE=2 SV=1,GO:0000139; GO:0000271; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0007033; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0010803; GO:0014033; GO:0015012; GO:0015020; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030199; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1902494; GO:1904888; GO:1990823,"antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; glycosaminoglycan biosynthetic process [GO:0006024]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal-level water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; polysaccharide biosynthetic process [GO:0000271]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]",catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; synapse [GO:0045202],acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003013; GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006790; GO:0006954; GO:0007155; GO:0009101; GO:0016740; GO:0023052; GO:0030154; GO:0030163; GO:0030198; GO:0034330; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0065003; GO:1901135,immune system process; circulatory system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; sulfur compound metabolic process; inflammatory response; cell adhesion; glycoprotein biosynthetic process; transferase activity; signaling; cell differentiation; protein catabolic process; extracellular matrix organization; cell junction organization; wound healing; organelle; anatomical structure development; cell motility; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_02910,1.6753060598253564,OG_02910,FUN_011987-T1,Peve_00000526,Pocillopora_meandrina_HIv1___RNAseq.g23712.t1,three_way,80.10666666666667,FUN_011987-T1,Q9ULU4,,,,,39.1,266.0,5e-53,210.7,sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,,,,,,
OG_02910,1.6753060598253564,OG_02910,FUN_011987-T1,Peve_00000526,Pocillopora_meandrina_HIv1___RNAseq.g23712.t1,three_way,80.10666666666667,FUN_011987-T1,Q9ULU4,,,,,55.6,36.0,3.2e-07,58.5,sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,,,,,,
OG_04247,1.6733784661416964,OG_04247,FUN_017773-T1,Peve_00016058,Pocillopora_meandrina_HIv1___RNAseq.g448.t1,three_way,76.1215,FUN_017773-T1,P48746,,,,,41.1,915.0,2.4000000000000002e-182,641.0,sp|P48746|B3A2_RABIT Anion exchange protein 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC4A2 PE=1 SV=1,,,,,,
OG_07731,1.6733049374094715,OG_07731,FUN_034892-T1,Peve_00037338,Pocillopora_meandrina_HIv1___TS.g15150.t1,three_way,61.52,,,,,,,,,,,,,,,,,
OG_09888,1.6699863051251311,OG_09888,FUN_042963-T1,Peve_00039045,Pocillopora_meandrina_HIv1___RNAseq.4783_t,three_way,65.88283333333334,FUN_042963-T1,Q4VGL6,RC3H1_MOUSE,,Roquin-1 (Roquin) (EC 2.3.2.27) (Protein Sanroque) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1),Mus musculus (Mouse),60.2,523.0,1.3e-165,585.5,sp|Q4VGL6|RC3H1_MOUSE Roquin-1 OS=Mus musculus OX=10090 GN=Rc3h1 PE=1 SV=1,GO:0000184; GO:0000209; GO:0000288; GO:0000932; GO:0000956; GO:0001782; GO:0002634; GO:0002635; GO:0003725; GO:0003729; GO:0003730; GO:0004842; GO:0005737; GO:0008270; GO:0010468; GO:0010494; GO:0010608; GO:0030889; GO:0033962; GO:0035198; GO:0035613; GO:0042098; GO:0043029; GO:0043488; GO:0045623; GO:0046007; GO:0048535; GO:0048536; GO:0050852; GO:0050856; GO:0061014; GO:0061158; GO:0061470; GO:0071347; GO:1900151; GO:1901224; GO:1905762; GO:2000320; GO:2000628,"3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; P-body assembly [GO:0033962]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900151]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932],CCR4-NOT complex binding [GO:1905762]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0016071; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; RNA binding; catalytic activity; mRNA metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00843,1.668222945952007,OG_00843,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_08410,1.661511518190426,OG_08410,FUN_037061-T1,Peve_00018395,Pocillopora_meandrina_HIv1___RNAseq.g26778.t1,three_way,63.92483333333333,FUN_037061-T1,Q5U2U2,CRKL_RAT,,Crk-like protein,Rattus norvegicus (Rat),37.5,293.0,5.8e-46,186.0,sp|Q5U2U2|CRKL_RAT Crk-like protein OS=Rattus norvegicus OX=10116 GN=Crkl PE=1 SV=1,GO:0001558; GO:0001568; GO:0001655; GO:0001764; GO:0001783; GO:0001784; GO:0002685; GO:0003151; GO:0005654; GO:0005737; GO:0005829; GO:0006629; GO:0007167; GO:0007283; GO:0007338; GO:0007389; GO:0007507; GO:0008284; GO:0008543; GO:0008584; GO:0009887; GO:0009952; GO:0010468; GO:0010629; GO:0016358; GO:0016477; GO:0021766; GO:0021987; GO:0030010; GO:0030971; GO:0031594; GO:0032991; GO:0033628; GO:0035022; GO:0035591; GO:0035685; GO:0038026; GO:0042802; GO:0043410; GO:0045202; GO:0048384; GO:0048538; GO:0050773; GO:0050852; GO:0060017; GO:0060326; GO:0060392; GO:0061629; GO:0070374; GO:0071466; GO:0071560; GO:0071774; GO:0086100; GO:0095500; GO:0098698; GO:0098749; GO:0098761; GO:0098890; GO:0160093; GO:1900026; GO:1903977; GO:1904393; GO:1904395; GO:1904888; GO:2000404,acetylcholine receptor signaling pathway [GO:0095500]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; chordate pharynx development [GO:0160093]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of gene expression [GO:0010468]; regulation of leukocyte migration [GO:0002685]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; regulation of T cell migration [GO:2000404]; response to fibroblast growth factor [GO:0071774]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; synapse [GO:0045202],identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591],GO:0002376; GO:0005654; GO:0005829; GO:0006629; GO:0007163; GO:0012501; GO:0022414; GO:0048856; GO:0048870; GO:0060090,immune system process; nucleoplasm; cytosol; lipid metabolic process; establishment or maintenance of cell polarity; programmed cell death; reproductive process; anatomical structure development; cell motility; molecular adaptor activity
OG_02317,1.6587876116193754,OG_02317,FUN_008908-T1,Peve_00017912,Pocillopora_meandrina_HIv1___TS.g30016.t1,three_way,61.309333333333335,FUN_008908-T1,G8HTB6,,,,,95.7,349.0,1.3e-187,657.1,sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05672,1.658055365315002,OG_05672,FUN_025466-T1,Peve_00043837,Pocillopora_meandrina_HIv1___RNAseq.g13240.t1,three_way,86.86633333333333,FUN_025466-T1,Q8VDJ3,,,,,52.2,1291.0,0.0,1320.8,sp|Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus OX=10090 GN=Hdlbp PE=1 SV=1,,,,,,
OG_04046,1.6578646134559367,OG_04046,FUN_016360-T1,Peve_00004338,Pocillopora_meandrina_HIv1___RNAseq.g9672.t1,three_way,64.9715,FUN_016360-T1,Q9Y6R0,NUMBL_HUMAN,,Numb-like protein (Numb-related protein) (Numb-R),Homo sapiens (Human),58.1,160.0,1e-46,189.5,sp|Q9Y6R0|NUMBL_HUMAN Numb-like protein OS=Homo sapiens OX=9606 GN=NUMBL PE=1 SV=1,GO:0005737; GO:0007399; GO:0007409; GO:0019221; GO:0019538; GO:0021670; GO:0021849; GO:0034332; GO:0050769; GO:0050775; GO:0098978; GO:0150052,adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cytokine-mediated signaling pathway [GO:0019221]; lateral ventricle development [GO:0021670]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neurogenesis [GO:0050769]; protein metabolic process [GO:0019538]; regulation of postsynapse assembly [GO:0150052],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978],,GO:0034330; GO:0048856,cell junction organization; anatomical structure development
OG_08346,1.6557232652196614,OG_08346,FUN_036879-T1,Peve_00006949,Pocillopora_meandrina_HIv1___RNAseq.g10628.t1,three_way,88.30766666666666,FUN_036879-T1,Q27128,PAPSS_URECA,,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPS synthetase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],Urechis caupo (Innkeeper worm) (Spoonworm),71.9,597.0,1.0999999999999999e-265,917.1,sp|Q27128|PAPSS_URECA Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase OS=Urechis caupo OX=6431 PE=1 SV=1,GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779; GO:0050428,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103],,adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781],GO:0003824; GO:0006790; GO:0016740; GO:0055086; GO:1901135,catalytic activity; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02472,1.651953878092438,OG_02472,FUN_009674-T1,Peve_00009258,Pocillopora_meandrina_HIv1___RNAseq.g24570.t1,three_way,65.10866666666666,FUN_009674-T1,Q7ZW47,,,,,34.7,625.0,1.4e-71,272.3,sp|Q7ZW47|STAU2_DANRE Double-stranded RNA-binding protein Staufen homolog 2 OS=Danio rerio OX=7955 GN=stau2 PE=2 SV=2,,,,,,
OG_04454,1.6467064966667817,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,41.9,508.0,1.3e-103,382.9,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04454,1.6467064966667817,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,32.7,107.0,8.6e-10,71.2,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_03309,1.6466040401484725,OG_03309,FUN_013385-T1,Peve_00015992,Pocillopora_meandrina_HIv1___RNAseq.g22980.t2,three_way,65.83083333333333,FUN_013385-T1,Q24180,DEAF1_DROME,,Deformed epidermal autoregulatory factor 1 (Protein DEAF-1),Drosophila melanogaster (Fruit fly),45.2,84.0,2.6e-16,87.8,sp|Q24180|DEAF1_DROME Deformed epidermal autoregulatory factor 1 OS=Drosophila melanogaster OX=7227 GN=Deaf1 PE=1 SV=1,GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776,embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]; polytene chromosome [GO:0005700],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005694; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; chromosome; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_08313,1.6456340131779414,OG_08313,FUN_036513-T1,Peve_00031408,Pocillopora_meandrina_HIv1___RNAseq.g27052.t1,three_way,58.79833333333333,FUN_036513-T1,A0A8I3PDQ1,CASL_CANLF,,Enhancer of filamentation 1 (CRK-associated substrate-related protein) (CAS-L) (Neural precursor cell expressed developmentally down-regulated protein 9) (NEDD-9) (p105),Canis lupus familiaris (Dog) (Canis familiaris),22.2,968.0,2.6e-26,122.5,sp|A0A8I3PDQ1|CASL_CANLF Enhancer of filamentation 1 OS=Canis lupus familiaris OX=9615 GN=NEDD9 PE=1 SV=1,GO:0000922; GO:0001772; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0005938; GO:0007155; GO:0007169; GO:0007611; GO:0016323; GO:0016477; GO:0030027; GO:0030336; GO:0032956; GO:0036064; GO:0045672; GO:0051301; GO:0061523; GO:0072686; GO:0097021; GO:0140131; GO:1900026; GO:1902952; GO:1903829; GO:1990782; GO:2000522,cell adhesion [GO:0007155]; cell division [GO:0051301]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cilium disassembly [GO:0061523]; learning or memory [GO:0007611]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of lymphocyte chemotaxis [GO:0140131]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein localization [GO:1903829]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956],basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0007155; GO:0043226; GO:0044782; GO:0048870; GO:0050877,immune system process; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; cell adhesion; organelle; cilium organization; cell motility; nervous system process
OG_05718,1.6421320009011022,OG_05718,FUN_025610-T1,Peve_00009537,Pocillopora_meandrina_HIv1___RNAseq.g23128.t1,three_way,58.688833333333335,FUN_025610-T1,Q07497,,,,,34.9,935.0,3.6999999999999996e-147,523.9,sp|Q07497|EPHB5_CHICK Ephrin type-B receptor 5 OS=Gallus gallus OX=9031 GN=EPHB5 PE=2 SV=1,,,,,,
OG_08484,1.640475495782669,OG_08484,FUN_037320-T1,Peve_00006220,Pocillopora_meandrina_HIv1___RNAseq.g10703.t1,three_way,66.359,FUN_037320-T1,A2VE04,FRRS1_BOVIN,,Ferric-chelate reductase 1 (EC 1.-.-.-),Bos taurus (Bovine),29.7,202.0,6.1e-07,57.4,sp|A2VE04|FRRS1_BOVIN Ferric-chelate reductase 1 OS=Bos taurus OX=9913 GN=FRRS1 PE=2 SV=1,GO:0006879; GO:0016020; GO:0016722; GO:0046872,intracellular iron ion homeostasis [GO:0006879],membrane [GO:0016020],"metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]",GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_08852,1.6342155828478315,OG_08852,FUN_038217-T1,Peve_00038841,Pocillopora_meandrina_HIv1___RNAseq.g901.t2,three_way,66.15016666666666,FUN_038217-T1,Q9UKN7,,,,,32.5,2688.0,0.0,1096.6,sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2,,,,,,
OG_00570,1.6312596091877751,OG_00570,FUN_001628-T1,Peve_00009929,Pocillopora_meandrina_HIv1___RNAseq.g2165.t1,three_way,85.88366666666667,FUN_001628-T1,P49706,,,,,57.9,290.0,2.8e-88,326.6,sp|P49706|CCND2_CHICK G1/S-specific cyclin-D2 OS=Gallus gallus OX=9031 GN=CCND2 PE=3 SV=1,,,,,,
OG_01576,1.6308601503235751,OG_01576,FUN_006581-T1,Peve_00015613,Pocillopora_meandrina_HIv1___RNAseq.g20271.t1,three_way,58.029,FUN_006581-T1,P18460,,,,,34.3,769.0,1.3e-91,339.3,sp|P18460|FGFR3_CHICK Fibroblast growth factor receptor 3 OS=Gallus gallus OX=9031 GN=FGFR3 PE=2 SV=1,,,,,,
OG_05755,1.6303999966546907,OG_05755,FUN_025690-T1,Peve_00005581,Pocillopora_meandrina_HIv1___RNAseq.g13163.t2b,three_way,57.99366666666667,,,,,,,,,,,,,,,,,
OG_03451,1.6291026276846263,OG_03451,FUN_014525-T1,Peve_00044380,Pocillopora_meandrina_HIv1___RNAseq.g22618.t1,three_way,89.524,FUN_014525-T1,Q7PPA5,,,,,70.7,996.0,0.0,1408.7,sp|Q7PPA5|ATC1_ANOGA Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type OS=Anopheles gambiae OX=7165 GN=SERCA PE=3 SV=5,,,,,,
OG_02998,1.6282246574621353,OG_02998,FUN_012177-T1,Peve_00040996,Pocillopora_meandrina_HIv1___RNAseq.g23859.t1,three_way,91.90766666666669,FUN_012177-T1,P18654,KS6A3_MOUSE,,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),Mus musculus (Mouse),67.4,742.0,1e-291,1003.8,sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2,GO:0000287; GO:0002224; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0019901; GO:0032496; GO:0035556; GO:0043066; GO:0045944; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08859,1.6272044171891202,OG_08859,FUN_038245-T1,Peve_00007985,Pocillopora_meandrina_HIv1___TS.g5460.t2,three_way,84.75483333333334,FUN_038245-T1,P24733,,,,,61.2,841.0,5e-306,1052.7,"sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1",,,,,,
OG_05207,1.624793835960151,OG_05207,FUN_023591-T1,Peve_00023917,Pocillopora_meandrina_HIv1___RNAseq.g3310.t1,three_way,53.26583333333333,FUN_023591-T1,A7Z035,EPN4_BOVIN,,Clathrin interactor 1 (Epsin-4),Bos taurus (Bovine),38.2,626.0,8.3e-77,289.7,sp|A7Z035|EPN4_BOVIN Clathrin interactor 1 OS=Bos taurus OX=9913 GN=CLINT1 PE=2 SV=1,GO:0005543; GO:0005654; GO:0005768; GO:0005798; GO:0005802; GO:0005886; GO:0006897; GO:0030125; GO:0030276; GO:0048471,endocytosis [GO:0006897],clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; Golgi-associated vesicle [GO:0005798]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],clathrin binding [GO:0030276]; phospholipid binding [GO:0005543],GO:0005654; GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; endosome; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_01954,1.6213309704188976,OG_01954,FUN_008020-T1,Peve_00031302,Pocillopora_meandrina_HIv1___RNAseq.g30341.t1,three_way,85.20216666666667,FUN_008020-T1,P27448,MARK3_HUMAN,,MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78),Homo sapiens (Human),52.2,826.0,3.2000000000000005e-201,703.4,sp|P27448|MARK3_HUMAN MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens OX=9606 GN=MARK3 PE=1 SV=5,GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0048156; GO:0050321; GO:0070062; GO:0106310; GO:1900181,intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005829; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07477,1.6137187360192808,OG_07477,FUN_033999-T1,Peve_00044495,Pocillopora_meandrina_HIv1___RNAseq.g9828.t1,three_way,84.30799999999999,FUN_033999-T1,Q9F234,,,,,29.2,854.0,2.3e-86,322.0,sp|Q9F234|AGL2_BACTQ Alpha-glucosidase 2 OS=Bacillus thermoamyloliquefaciens OX=1425 PE=3 SV=1,,,,,,
OG_08937,1.6095351191967318,OG_08937,FUN_038401-T1,Peve_00000033,Pocillopora_meandrina_HIv1___RNAseq.g28276.t1,three_way,76.06083333333333,FUN_038401-T1,Q9BG91,,,,,65.5,148.0,5e-50,200.3,sp|Q9BG91|SOX9_CALJA Transcription factor SOX-9 OS=Callithrix jacchus OX=9483 GN=SOX9 PE=2 SV=1,,,,,,
OG_04627,1.608519500700936,OG_04627,FUN_022340-T1,Peve_00028608,Pocillopora_meandrina_HIv1___RNAseq.g4654.t1,three_way,62.08733333333333,FUN_022340-T1,Q63258,ITA7_RAT,,Integrin alpha-7 (H36-alpha7) [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form],Rattus norvegicus (Rat),27.7,1149.0,3.1e-87,325.1,sp|Q63258|ITA7_RAT Integrin alpha-7 OS=Rattus norvegicus OX=10116 GN=Itga7 PE=1 SV=2,GO:0005178; GO:0005737; GO:0005927; GO:0007155; GO:0007229; GO:0007519; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016477; GO:0031594; GO:0033627; GO:0034113; GO:0034677; GO:0035987; GO:0042383; GO:0043236; GO:0044877; GO:0046872; GO:0048514; GO:0050839; GO:0050900; GO:0098609,blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519],cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integrin alpha7-beta1 complex [GO:0034677]; integrin complex [GO:0008305]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383],cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0002376; GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0048870,immune system process; plasma membrane; cell adhesion; cell differentiation; anatomical structure development; cell motility
OG_07121,1.6082667341280918,OG_07121,FUN_032420-T1,Peve_00041753,Pocillopora_meandrina_HIv1___RNAseq.g24395.t1,three_way,71.22583333333333,,,,,,,,,,,,,,,,,
OG_03946,1.607070259660636,OG_03946,FUN_016083-T1,Peve_00021930,Pocillopora_meandrina_HIv1___RNAseq.g21608.t1,three_way,63.108,FUN_016083-T1,Q503L9,NXN_DANRE,,Nucleoredoxin (EC 1.8.1.8),Danio rerio (Zebrafish) (Brachydanio rerio),44.6,413.0,5.8e-95,349.4,sp|Q503L9|NXN_DANRE Nucleoredoxin OS=Danio rerio OX=7955 GN=nxn PE=2 SV=1,GO:0004791; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0072359,cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleus [GO:0005634],thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005829; GO:0016209; GO:0016491; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; antioxidant activity; oxidoreductase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04256,1.6066995444910688,OG_04256,FUN_017787-T1,Peve_00040530,Pocillopora_meandrina_HIv1___RNAseq.g9522.t1,three_way,41.8165,FUN_017787-T1,Q5VT06,CE350_HUMAN,,Centrosome-associated protein 350 (Cep350) (Centrosome-associated protein of 350 kDa),Homo sapiens (Human),39.4,66.0,1.1e-06,56.2,sp|Q5VT06|CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens OX=9606 GN=CEP350 PE=1 SV=1,GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0008017; GO:0016020; GO:0034453; GO:0036064; GO:0043231; GO:0071539; GO:1905515,microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008092; GO:0043226; GO:0044782,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; cytoskeletal protein binding; organelle; cilium organization
OG_06125,1.6064695897016452,OG_06125,FUN_027903-T1,Peve_00020107,Pocillopora_meandrina_HIv1___RNAseq.g13881.t1,three_way,48.315666666666665,FUN_027903-T1,O75487,GPC4_HUMAN,,Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4],Homo sapiens (Human),33.5,507.0,6.5e-73,276.6,sp|O75487|GPC4_HUMAN Glypican-4 OS=Homo sapiens OX=9606 GN=GPC4 PE=1 SV=4,GO:0005634; GO:0005796; GO:0005886; GO:0009897; GO:0009966; GO:0009986; GO:0015026; GO:0016055; GO:0016477; GO:0043202; GO:0045202; GO:0070062; GO:0098696; GO:0098978; GO:0099560; GO:1905606,cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],coreceptor activity [GO:0015026],GO:0005634; GO:0005886; GO:0007155; GO:0043226; GO:0048870; GO:0060089,nucleus; plasma membrane; cell adhesion; organelle; cell motility; molecular transducer activity
OG_00141,1.6062506200194449,OG_00141,FUN_000580-T1,Peve_00034764,Pocillopora_meandrina_HIv1___RNAseq.g29301.t1,three_way,44.83516666666667,FUN_000580-T1,Q7KM13,,,,,30.5,164.0,6.6e-08,60.5,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_07112,1.6026983097118983,OG_07112,FUN_032385-T1,Peve_00007850,Pocillopora_meandrina_HIv1___RNAseq.g29733.t1,three_way,82.91166666666666,FUN_032385-T1,P52649,,,,,54.6,467.0,1.3e-138,494.6,sp|P52649|CY24B_PIG NADPH oxidase 2 OS=Sus scrofa OX=9823 GN=CYBB PE=2 SV=3,,,,,,
OG_00629,1.6021484934987615,OG_00629,FUN_001847-T1,Peve_00025829,Pocillopora_meandrina_HIv1___RNAseq.g2613.t1,three_way,82.766,FUN_001847-T1,O88576,S6A18_MOUSE,,Sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3),Mus musculus (Mouse),51.0,486.0,7.500000000000001e-145,515.4,sp|O88576|S6A18_MOUSE Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Mus musculus OX=10090 GN=Slc6a18 PE=1 SV=1,GO:0003333; GO:0005886; GO:0006836; GO:0015175; GO:0015804; GO:0016324; GO:0031526; GO:0140931; GO:1990297,amino acid transmembrane transport [GO:0003333]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; renal amino acid absorption [GO:1990297],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],neutral L-amino acid transmembrane transporter activity [GO:0015175]; neutral L-amino acid:sodium:chloride symporter activity [GO:0140931],GO:0003014; GO:0005215; GO:0005886; GO:0055085,renal system process; transporter activity; plasma membrane; transmembrane transport
OG_00145,1.5975842203350734,OG_00145,FUN_000588-T1,Peve_00025320,Pocillopora_meandrina_HIv1___RNAseq.g29293.t3,three_way,87.40333333333334,FUN_000588-T1,P28347,TEAD1_HUMAN,,Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13),Homo sapiens (Human),65.6,450.0,3.6000000000000002e-146,519.6,sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837,embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_07579,1.595507119198531,OG_07579,FUN_034260-T1,Peve_00009311,Pocillopora_meandrina_HIv1___RNAseq.g26620.t1,three_way,74.869,FUN_034260-T1,Q9H2X6,HIPK2_HUMAN,,Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1),Homo sapiens (Human),49.5,662.0,4.4e-159,563.9,sp|Q9H2X6|HIPK2_HUMAN Homeodomain-interacting protein kinase 2 OS=Homo sapiens OX=9606 GN=HIPK2 PE=1 SV=2,GO:0000122; GO:0001654; GO:0003016; GO:0003713; GO:0003714; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007179; GO:0007224; GO:0007628; GO:0008283; GO:0008284; GO:0009952; GO:0010467; GO:0010494; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0030182; GO:0030218; GO:0030330; GO:0030511; GO:0030514; GO:0030578; GO:0030878; GO:0040029; GO:0042771; GO:0043524; GO:0045766; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051402; GO:0051726; GO:0060059; GO:0060235; GO:0060395; GO:0060425; GO:0061072; GO:0061629; GO:0071456; GO:0090575; GO:0097193; GO:0106310; GO:1901796; GO:2000059,"adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cell population proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; gene expression [GO:0010467]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; lung morphogenesis [GO:0060425]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of JNK cascade [GO:0046330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; respiratory system process [GO:0003016]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790],GO:0003016; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140096; GO:0140110,"respiratory system process; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; programmed cell death; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_09573,1.5928692223818015,OG_09573,FUN_041705-T1,Peve_00001480,Pocillopora_meandrina_HIv1___RNAseq.g13973.t1,three_way,45.37833333333334,FUN_041705-T1,Q95VY2,,,,,43.7,174.0,1.7000000000000002e-32,140.6,sp|Q95VY2|TCTP_BRABE Translationally-controlled tumor protein homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1,,,,,,
OG_06663,1.5921049059665988,OG_06663,FUN_031054-T1,Peve_00028185,Pocillopora_meandrina_HIv1___RNAseq.g30322.t1,three_way,84.973,FUN_031054-T1,Q8CIB5,FERM2_MOUSE,,Fermitin family homolog 2 (Kindlin-2) (Pleckstrin homology domain-containing family C member 1),Mus musculus (Mouse),47.4,694.0,4.1000000000000004e-170,599.7,sp|Q8CIB5|FERM2_MOUSE Fermitin family homolog 2 OS=Mus musculus OX=10090 GN=Fermt2 PE=1 SV=1,GO:0001725; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005912; GO:0005925; GO:0005938; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009898; GO:0009986; GO:0010718; GO:0016055; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035025; GO:0043116; GO:0043539; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0070374; GO:0072657; GO:0120283; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691,"adherens junction maintenance [GO:0034334]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]",adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; I band [GO:0031674]; lamellipodium membrane [GO:0031258]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725],"actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; SMAD binding [GO:0046332]; type I transforming growth factor beta receptor binding [GO:0034713]",GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0007155; GO:0008092; GO:0008289; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,circulatory system process; nucleus; nucleoplasm; cytosol; cell adhesion; cytoskeletal protein binding; lipid binding; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_00913,1.588839339531097,OG_00913,FUN_004247-T1,Peve_00019440,Pocillopora_meandrina_HIv1___RNAseq.g11529.t1,three_way,67.11033333333333,FUN_004247-T1,P41233,,,,,40.9,2521.0,0.0,1671.4,sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4,,,,,,
OG_10160,1.5866381117590287,OG_10160,FUN_043558-T1,Peve_00022071,Pocillopora_meandrina_HIv1___RNAseq.g8044.t1,three_way,60.96266666666666,,,,,,,,,,,,,,,,,
OG_09530,1.5858709752569438,OG_09530,FUN_041607-T1,Peve_00026860,Pocillopora_meandrina_HIv1___RNAseq.g15307.t1,three_way,78.76933333333334,FUN_041607-T1,P49748,ACADV_HUMAN,,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)",Homo sapiens (Human),64.5,595.0,5.3e-212,738.8,"sp|P49748|ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADVL PE=1 SV=1",GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0042645; GO:0042802; GO:0045717; GO:0046322; GO:0050660; GO:0090181,energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain fatty acyl-CoA dehydrogenase activity [GO:0017099],GO:0003824; GO:0005654; GO:0005730; GO:0005739; GO:0006091; GO:0006629; GO:0008289; GO:0016491; GO:0030154; GO:0043226,catalytic activity; nucleoplasm; nucleolus; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; lipid binding; oxidoreductase activity; cell differentiation; organelle
OG_02805,1.5855312261345866,OG_02805,FUN_011776-T1,Peve_00006118,Pocillopora_meandrina_HIv1___RNAseq.g23292.t1,three_way,81.48183333333333,FUN_011776-T1,Q01196,RUNX1_HUMAN,,Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit),Homo sapiens (Human),48.8,320.0,7.1e-71,269.6,sp|Q01196|RUNX1_HUMAN Runt-related transcription factor 1 OS=Homo sapiens OX=9606 GN=RUNX1 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001503; GO:0002062; GO:0002573; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005634; GO:0005654; GO:0006357; GO:0010755; GO:0016513; GO:0030097; GO:0030099; GO:0030182; GO:0030853; GO:0030854; GO:0032743; GO:0032967; GO:0042803; GO:0043231; GO:0043371; GO:0043378; GO:0045595; GO:0045766; GO:0045893; GO:0045944; GO:0046982; GO:0048935; GO:0060043; GO:0061026; GO:0071425; GO:0140297; GO:1903055; GO:1905203,"cardiac muscle tissue regeneration [GO:0061026]; chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell differentiation [GO:0045595]; regulation of connective tissue replacement [GO:1905203]; regulation of plasminogen activation [GO:0010755]; regulation of transcription by RNA polymerase II [GO:0006357]",chromatin [GO:0000785]; core-binding factor complex [GO:0016513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04880,1.5843945657580532,OG_04880,FUN_022914-T1,Peve_00001826,Pocillopora_meandrina_HIv1___RNAseq.g3710.t1,three_way,80.40933333333334,FUN_022914-T1,Q63028,ADDA_RAT,,Alpha-adducin (Erythrocyte adducin subunit alpha),Rattus norvegicus (Rat),47.2,375.0,3.7e-87,323.9,sp|Q63028|ADDA_RAT Alpha-adducin OS=Rattus norvegicus OX=10116 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0005200; GO:0005516; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006811; GO:0006884; GO:0007010; GO:0008290; GO:0014069; GO:0016020; GO:0020027; GO:0030218; GO:0030425; GO:0030507; GO:0030837; GO:0035264; GO:0042608; GO:0042803; GO:0043197; GO:0045202; GO:0045766; GO:0045807; GO:0046982; GO:0046983; GO:0048471; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0061629; GO:0071277; GO:0071300; GO:1903142; GO:1903393,actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; cytoskeleton organization [GO:0007010]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; monoatomic ion transport [GO:0006811]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; T cell receptor binding [GO:0042608],GO:0005198; GO:0005634; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; nucleus; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_10051,1.5841131578090968,OG_10051,FUN_043325-T1,Peve_00043035,Pocillopora_meandrina_HIv1___RNAseq.g8952.t1,three_way,72.11733333333333,FUN_043325-T1,Q2HWF0,FBP1L_RAT,,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),Rattus norvegicus (Rat),31.6,604.0,1.9000000000000002e-74,281.6,sp|Q2HWF0|FBP1L_RAT Formin-binding protein 1-like OS=Rattus norvegicus OX=10116 GN=Fnbp1l PE=1 SV=2,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0007399; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0030154; GO:0031410; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320,autophagy [GO:0006914]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; nervous system development [GO:0007399]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886],GTPase binding [GO:0051020]; lipid binding [GO:0008289],GO:0005829; GO:0005856; GO:0005886; GO:0006914; GO:0008289; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0061024,cytosol; cytoskeleton; plasma membrane; autophagy; lipid binding; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; membrane organization
OG_05669,1.5834287374124545,OG_05669,FUN_025459-T1,Peve_00005466,Pocillopora_meandrina_HIv1___RNAseq.g13245.t1,three_way,94.06666666666666,FUN_025459-T1,Q2KJ93,CDC42_BOVIN,,Cell division control protein 42 homolog (EC 3.6.5.2),Bos taurus (Bovine),90.6,191.0,9e-99,360.9,sp|Q2KJ93|CDC42_BOVIN Cell division control protein 42 homolog OS=Bos taurus OX=9913 GN=CDC42 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005813; GO:0005886; GO:0006897; GO:0006911; GO:0007015; GO:0007165; GO:0007264; GO:0016020; GO:0019901; GO:0030010; GO:0030425; GO:0030496; GO:0031258; GO:0032467; GO:0034329; GO:0045198; GO:0048549; GO:0051233; GO:0051489; GO:0051491; GO:0051988; GO:0060997; GO:0072686; GO:1900026,"actin filament organization [GO:0007015]; cell junction assembly [GO:0034329]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of pinocytosis [GO:0048549]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005815; GO:0005886; GO:0007163; GO:0016192; GO:0016787; GO:0030154; GO:0034330; GO:0043226; GO:0061024; GO:0098772,catalytic activity; GTPase activity; microtubule organizing center; plasma membrane; establishment or maintenance of cell polarity; vesicle-mediated transport; hydrolase activity; cell differentiation; cell junction organization; organelle; membrane organization; molecular function regulator activity
OG_04244,1.5833948558517126,OG_04244,FUN_017766-T1,Peve_00035953,Pocillopora_meandrina_HIv1___RNAseq.g462.t1,three_way,86.78283333333333,FUN_017766-T1,P19517,,,,,56.8,405.0,1.8e-114,414.5,sp|P19517|CACB1_RABIT Voltage-dependent L-type calcium channel subunit beta-1 OS=Oryctolagus cuniculus OX=9986 GN=CACNB1 PE=1 SV=1,,,,,,
OG_01297,1.5825085381457276,OG_01297,FUN_005131-T1,Peve_00027431,Pocillopora_meandrina_HIv1___RNAseq.g22688.t1,three_way,57.669,FUN_005131-T1,P12256,,,,,31.2,321.0,7.1e-39,162.9,sp|P12256|PAC_LYSSH Penicillin V acylase OS=Lysinibacillus sphaericus OX=1421 PE=1 SV=1,,,,,,
OG_03209,1.581654004113506,OG_03209,FUN_012701-T1,Peve_00016835,Pocillopora_meandrina_HIv1___RNAseq.g12828.t1,three_way,66.00966666666667,,,,,,,,,,,,,,,,,
OG_03274,1.5810271096325117,OG_03274,FUN_013153-T1,Peve_00022450,Pocillopora_meandrina_HIv1___RNAseq.g12978.t1,three_way,39.60333333333333,,,,,,,,,,,,,,,,,
